The critical role of Sirt1 in ischemic stroke

Ischemic stroke, the most prevalent form of stroke, is responsible for the highest disability rates globally and ranks as the primary cause of mortality worldwide. Sirt1, extensively investigated in neurodegenerative disorders, is the most well-known and earliest member of the sirtuins family. Howev...

Full description

Saved in:
Bibliographic Details
Main Authors: Ziyi Jia, Ke Xu, Ruobing Li, Siyu Yang, Long Chen, Qianwen Zhang, Shulin Li, Xiaowei Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1425560/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850036945305993216
author Ziyi Jia
Ke Xu
Ruobing Li
Siyu Yang
Long Chen
Qianwen Zhang
Shulin Li
Xiaowei Sun
author_facet Ziyi Jia
Ke Xu
Ruobing Li
Siyu Yang
Long Chen
Qianwen Zhang
Shulin Li
Xiaowei Sun
author_sort Ziyi Jia
collection DOAJ
description Ischemic stroke, the most prevalent form of stroke, is responsible for the highest disability rates globally and ranks as the primary cause of mortality worldwide. Sirt1, extensively investigated in neurodegenerative disorders, is the most well-known and earliest member of the sirtuins family. However, its mechanism of action during ischemic stroke remains ambiguous. The literature examination revealed the intricate involvement of Sirt1 in regulating both physiological and pathological mechanisms during ischemic stroke. Sirt1 demonstrates deacetylation effects on PGC-1α, HMGB1, FOXOs, and p53. It hinders the activation of NLRP3 inflammasome and NF-κB while also engaging with AMPK. It regulates inflammatory response, oxidative stress, mitochondrial dysfunction, autophagy, pro-death, and necrotic apoptosis. Therefore, the potential of Sirt1 as a therapeutic target for the management of ischemic stroke is promising.
format Article
id doaj-art-e70e8ea95ffd4f058bebab13ac08fdf8
institution DOAJ
issn 1663-9812
language English
publishDate 2025-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-e70e8ea95ffd4f058bebab13ac08fdf82025-08-20T02:57:00ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-03-011610.3389/fphar.2025.14255601425560The critical role of Sirt1 in ischemic strokeZiyi Jia0Ke Xu1Ruobing Li2Siyu Yang3Long Chen4Qianwen Zhang5Shulin Li6Xiaowei Sun7The First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, ChinaThe Second Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, ChinaThe First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, ChinaThe Second Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, ChinaThe Fourth Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, ChinaThe First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, ChinaThe First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, ChinaThe First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, ChinaIschemic stroke, the most prevalent form of stroke, is responsible for the highest disability rates globally and ranks as the primary cause of mortality worldwide. Sirt1, extensively investigated in neurodegenerative disorders, is the most well-known and earliest member of the sirtuins family. However, its mechanism of action during ischemic stroke remains ambiguous. The literature examination revealed the intricate involvement of Sirt1 in regulating both physiological and pathological mechanisms during ischemic stroke. Sirt1 demonstrates deacetylation effects on PGC-1α, HMGB1, FOXOs, and p53. It hinders the activation of NLRP3 inflammasome and NF-κB while also engaging with AMPK. It regulates inflammatory response, oxidative stress, mitochondrial dysfunction, autophagy, pro-death, and necrotic apoptosis. Therefore, the potential of Sirt1 as a therapeutic target for the management of ischemic stroke is promising.https://www.frontiersin.org/articles/10.3389/fphar.2025.1425560/fullischemic strokeSIRT1inflammationoxidative stressautophagymitochondrial dysfunction
spellingShingle Ziyi Jia
Ke Xu
Ruobing Li
Siyu Yang
Long Chen
Qianwen Zhang
Shulin Li
Xiaowei Sun
The critical role of Sirt1 in ischemic stroke
Frontiers in Pharmacology
ischemic stroke
SIRT1
inflammation
oxidative stress
autophagy
mitochondrial dysfunction
title The critical role of Sirt1 in ischemic stroke
title_full The critical role of Sirt1 in ischemic stroke
title_fullStr The critical role of Sirt1 in ischemic stroke
title_full_unstemmed The critical role of Sirt1 in ischemic stroke
title_short The critical role of Sirt1 in ischemic stroke
title_sort critical role of sirt1 in ischemic stroke
topic ischemic stroke
SIRT1
inflammation
oxidative stress
autophagy
mitochondrial dysfunction
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1425560/full
work_keys_str_mv AT ziyijia thecriticalroleofsirt1inischemicstroke
AT kexu thecriticalroleofsirt1inischemicstroke
AT ruobingli thecriticalroleofsirt1inischemicstroke
AT siyuyang thecriticalroleofsirt1inischemicstroke
AT longchen thecriticalroleofsirt1inischemicstroke
AT qianwenzhang thecriticalroleofsirt1inischemicstroke
AT shulinli thecriticalroleofsirt1inischemicstroke
AT xiaoweisun thecriticalroleofsirt1inischemicstroke
AT ziyijia criticalroleofsirt1inischemicstroke
AT kexu criticalroleofsirt1inischemicstroke
AT ruobingli criticalroleofsirt1inischemicstroke
AT siyuyang criticalroleofsirt1inischemicstroke
AT longchen criticalroleofsirt1inischemicstroke
AT qianwenzhang criticalroleofsirt1inischemicstroke
AT shulinli criticalroleofsirt1inischemicstroke
AT xiaoweisun criticalroleofsirt1inischemicstroke